(1)
Remzi Akturk; Serdar Serinsöz. The Role of Mesalazine Co-Treatment in the Prevention of Recurrence in Subjects With Subclinical Inflammatory Bowel Disease and Perianal Fistula Who Are Scheduled for Surgical Intervention. Ann Ital Chir 2022, 93, 183-187.